Broadly neutralizing antibodies against influenza viruses.
about
The role of Fc-FcγR interactions in IgG-mediated microbial neutralizationRecurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.Passive broad-spectrum influenza immunoprophylaxisBroadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virusAn Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.Changes in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemicPriming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 virusesAdapting global influenza management strategies to address emerging viruses.Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses.Inhibition of highly pathogenic avian influenza (HPAI) virus by a peptide derived from vFLIP through its direct destabilization of viruses.Virus-vectored influenza virus vaccines.Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanismsVaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites.Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicityAdaptive Heterosubtypic Immunity to Low Pathogenic Avian Influenza Viruses in Experimentally Infected MallardsBroadly reactive aptamers targeting bacteria belonging to different genera using a sequential toggle cell-SELEXHigh Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A virusesDiscovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.Cross-reactive human B cell and T cell epitopes between influenza A and B viruses.Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine DesignA Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.Influenza reverse genetics: dissecting immunity and pathogenesis.Development and applications of single-cycle infectious influenza A virus (sciIAV).The role of structural proteomics in vaccine development: recent advances and future prospects.Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies?Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7.Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding.Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem.Age and different influenza virusesStructural insight into a human neutralizing antibody against influenza virus H7N9.Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries.
P2860
Q26797466-40F96CC8-0580-420C-8BC6-5CD2550B7560Q30145646-2F08D95F-845F-40F5-88EC-3F0C93E1034FQ30367936-75F5D02C-8DB1-41C5-AFDE-251A191FF14CQ30370793-D7780D71-3FBE-4A9F-BB43-9E64BC0C1586Q30377012-05578E0B-63A5-498A-BE7F-F4B990BF5A1FQ30377023-2B7171EC-0C53-456D-B7D5-050DABF88685Q30384225-593AF55A-7DDC-45D0-A188-6CE7472BEA3DQ30390832-BDAEF78B-114E-4812-BEEE-9AF84FF9418BQ30394447-81C96C1B-11A1-4C89-B911-D45F5C531A6AQ30431093-405150F1-9899-46E0-8CF4-982F791E8943Q33815658-E9B4714A-7816-4C22-81DE-6EDAF3B121B0Q33884759-D9759411-CE55-4531-96A9-F78CCF368604Q34102268-F0AD6503-788F-4435-85F6-906808A2E1AEQ35132253-E0915A39-8B64-402B-B5F7-591D64D22927Q35321520-4CC02FB7-4D40-4FE5-A3DB-269E635101CEQ35488279-FC4066AD-9E9B-4195-A814-ED68BF893844Q35910153-E7FC00AE-C0FA-4477-A5E9-54259CB646C6Q36003473-4B6BE733-DAD3-4C90-9D53-27767DFCE97AQ36255524-4E551DE6-C9DA-46FA-8F03-F947725C4644Q36300521-D63B1A69-2B19-460D-882A-B570A149A0FFQ36344790-691F2F4C-4E60-4779-9072-A033E055BCDCQ36611283-8B9F8E4B-602A-47DD-8D7A-8DF70BA41F74Q36791678-8A610949-0AE1-4673-9462-A6D098E37A36Q37053710-273C6BC0-64ED-4AE2-8FAC-65A1DE402857Q37252942-05BFE7DA-930C-485A-BEC6-71493180AF1CQ37714300-BEBAA3E4-EACE-4A58-B50B-ACC7541D638BQ38188084-F2F6F1C9-917C-4E44-9D14-4F0D584AEF00Q38556537-D49F4F69-7C43-4695-8931-BD6BA4ADB17BQ38682335-38E864F0-70F5-4603-8474-C3B89ACA4D53Q38727221-95C079DD-8466-44A1-B027-76AB01AB629EQ40065071-41EEAE8F-BDBC-4CDC-9884-B6CC553C0390Q40080908-3F8CF46D-001D-47D9-A4D2-B0B6567FE3B8Q40120056-CFF80DFE-2C0C-4D2E-AE6D-B08DE8067C35Q40152557-8B62A731-5FA9-4E3C-9F5C-4BB72063E1A4Q41922286-0A9F186E-52EA-492A-9EFD-EDFB49713986Q41933744-9F3CB7E8-EDBF-457C-BAB2-171623E078C9Q42753727-51CCB458-88B2-4D15-8A44-50E7566604D9Q45323700-BADC0439-6C30-44B9-B306-A09110BE6596Q45324307-C488779C-EB68-480B-9330-4346303C1A85Q45325444-FADBD44C-04E0-438C-857C-C0209B1887E7
P2860
Broadly neutralizing antibodies against influenza viruses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Broadly neutralizing antibodies against influenza viruses.
@en
Broadly neutralizing antibodies against influenza viruses.
@nl
type
label
Broadly neutralizing antibodies against influenza viruses.
@en
Broadly neutralizing antibodies against influenza viruses.
@nl
prefLabel
Broadly neutralizing antibodies against influenza viruses.
@en
Broadly neutralizing antibodies against influenza viruses.
@nl
P2860
P1433
P1476
Broadly neutralizing antibodies against influenza viruses.
@en
P2093
Ian A Wilson
Nick S Laursen
P2860
P304
P356
10.1016/J.ANTIVIRAL.2013.03.021
P577
2013-04-09T00:00:00Z